Molecular Markers in Mycology Diagnostics and Marker Developments /
The Kingdom fungi encompass a massive diversity of taxa with wide-ranging ecologies, life cycles, and morphologies ranging from unicellular aquatic chytrids to large mushrooms. Before molecular methods came in existence, taxonomists considered this Kingdom to be a member of the plant kingdom due to...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
Σειρά: | Fungal Biology,
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- 1. Molecular Diversity and Detection of Endophytic Fungi Based on Their Antimicrobial Biosynthetic Genes
- 2. Molecular Markers and Their Use in Taxonomic Characterization of Trichoderma spp
- 3. Molecular Diversity of Oleaginous Fungi from Virgin Soils and Their Potentiality of Biodiesel Production
- 4. Application of Real-Time PCR for Identification and Detection of Fungi
- 5. DNA Bar-Coding for Diagnostics and Monitoring of Plant Pathogens
- 6. New Generation DNA Markers for Fingerprinting and Structural Analysis of Fungal Community
- 7. Genic Markers in fungi: Availability and Utility for diagnostics
- 8. Molecular Markers for the Identification of Arbuscular Mycorrhizal Fungi (AMF) in the Soil and Plant Roots
- 9. Edible Mushroom Species: Identification Through Molecular Markers
- 10. Detection and Management of Fungal Respiratory Infection by Using Molecular Markers
- 11. Mitochondrial DNA Based Molecular Marker in Arbuscular Mycorrhizal Fungi (AMF) Research
- 12. Taxonomic Updates with Key Focus on Medically Important Aspergilli
- 13. Current Approach Towards Development of Molecular Markers in Diagnostics of Invasive Aspergillosis
- 14. An Overview of Major Fungal Diseases of Sugarcane in India: Detection and Management Strategies
- 15. Assessing Fungal Diversity by Using Molecular Markers
- 16. Detection of Multi Drug Resistant Fungal Infections in Cancer Patients by Using Molecular Markers.